API Product List
Active Pharmaceutical Ingredients
| S NO | PRODUCT | THERAPEUTIC INDICATION |
| 1 | BEMPEDOIC ACID – In House – USP | Hypercholesterolemia |
| 2 | DAPAGLIFLOZIN PROPANEDIOL – USP/In House | Antidiabetic |
| 3 | DONEPEZIL HYDROCHLORIDE – In House / USP / JP | Antialzheimer |
| 4 | DONEPEZIL HYDROCHLORIDE MONOHYDRATE – In House – USP | Antialzheimer |
| 5 | DOXAZOSIN MESYLATE – In House – USP | Antihypertension |
| 6 | EMPAGLIFLOZIN – In House | Antidiabetic |
| 7 | ESCITALOPRAM OXALATE – In House / USP / Ph.Eur | Antidepressant |
| 8 | MIROGABALIN BESYLATE – In House | Peripheral Neuropathic Pain / Diabetic Neuropathy |
| 9 | MONTELUKAST SODIUM – IP / Ph.Eur / USP | Anti-inflammatory / Asthma |
| 10 | OLANZAPINE – USP / Ph.Eur | Antipsychotic / Schizophrenia |
| 11 | ONDANSETRON HYDROCHLORIDE DIHYDRATE – USP / Ph.Eur | Antiemetic |
| 12 | RALOXIFENE HYDROCHLORIDE – USP / Ph.Eur | Osteoporosis |
| 13 | RESMETIROM – In House | Fatty liver |
| SUMATRIPTAN SUCCINATE – USP / Ph.Eur | Migraine | |
| 15 | TEGOPRAZAN – In House | GERD |
APIs Under Development
| S NO. | PRODUCT | THERAPEUTIC INDICATION |
| 1 | ENVOGLIFLOZIN | Type 2 diabetes |
| 2 | FEXUPRAZAN | GERD |
| 3 | FINERENONE | CKD with Type-2 Diabetes |
| 4 | ORFORGLIPRON | Weight Management / Type 2 Diabetes |
| 5 | RIMEGEPANT | Migraine |
| 6 | SOTAGLIFLOZIN | Type 2 diabetes |
| 7 | SUZETRIGINE | Pain Management – Non-opioid Analgesic |
| 8 | TAVABOROLE | Atopic Dermatitis / Anti-Fungal |
| 9 | UPADACITINIB | Rheumatoid Arthritis |
| 10 | VIBEGRON | Anti-Epileptic |
Let's Begin The Conversation
